Prospective Observational Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD.
Phase of Trial: Phase IV
Latest Information Update: 20 Feb 2015
At a glance
- Drugs Indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms INHALE
- Sponsors Novartis Pharmaceuticals
- 16 Jun 2014 New source identified and integrated (ClinicalTrials.gov: NCT02123199)
- 01 Oct 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 17 May 2012 New trial record